99,328 Shares in Dyne Therapeutics, Inc. (NASDAQ:DYN) Purchased by Raymond James Financial Inc.
Raymond James Financial Inc. purchased a new position in Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 99,328 shares of the company’s stock, valued at approximately $2,340,000. A number of other institutional investors also recently bought and sold shares of the business. Charles Schwab Investment Management […]
